What is Phaarmasia Ltd (523620) share price return in the past 10 years?

Phaarmasia Ltd share price has appreciated 10.8% annually (CAGR) over the past ten years.

What is the share price of Phaarmasia Ltd (523620)?

Company share prices are keep on changing according to the market conditions. The current trading price of Phaarmasia Ltd (523620) on 04-Jun-2026 16:59:59 at 16:59 is 83.47.

What is the P/E ratio of Phaarmasia?

The latest standalone P/E ratio of Phaarmasia as of 04-Jun-2026 is 3.24.

What is the P/B ratio of Phaarmasia Ltd (523620)?

The latest standalone P/B ratio of Phaarmasia Ltd (523620) as of 04-Jun-2026 is 2.58.

What is the 52-week high and low of Phaarmasia Ltd (523620)?

The 52-week high of Phaarmasia Ltd (523620) is Rs. 131.75 and the 52-week low is Rs. 26.00.

Phaarmasia Ltd (523620) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Phaarmasia Ltd (523620)
Brand: Phaarmasia

Phaarmasia Ltd (523620)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 523620 NSE: Pharmaceuticals & Drugs | Small Cap | Phaarmasia Share Price

Phaarmasia Ltd (523620)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 523620 NSE: Pharmaceuticals & Drugs | Small Cap | Phaarmasia Share Price

Key Metrics

Valuation Multiples

Market Cap

₹57 Cr.

Current Price

₹83.5

52-Week Low / High

₹26 / 132

TTM EPS

₹25.7

TTM Sales

₹47.2 Cr.

Book Value per Share

₹32.4

P/E Ratio

3.24

Industry PE

46.5

Price to Book (P/B)

2.58

In line with its 5-year historical median

Price to Sales (P/S)

1.21

Higher than its 5-year historical median

EV/EBITDA

16.62

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-30.12%

Underperforms industry median

Return on Capital Employed (ROCE)

-30.07%

Underperforms industry median

Return on Assets (ROA)

-6.00%

Operating Profit Margin

-8.3%

Net Profit Margin

-6.52%

Gross Profit Margin

-5.3%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-20.33%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

73.51%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹15 Cr.

Equity

₹6.8 Cr.

Face Value

₹10

All Time Low / High

₹0.05 / 420.00

Phaarmasia stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Phaarmasia Ltd a good quality company?

Phaarmasia Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Phaarmasia Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Phaarmasia Ltd vs industry peers?

Phaarmasia Ltd revenue CAGR is -0.07%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Phaarmasia Ltd?

Promoters hold 73.51% of the Phaarmasia Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Phaarmasia Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 10.5% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	3.4%	3.6%	9.3%	10.4%	11.1%	5.2%	-18%	-19.2%	-8%	-30.1%	-
Value Creation Index ⓘ	-0.8	-0.7	-0.3	-0.3	-0.2	-0.6	-2.3	-2.4	-1.6	-3.2	-
Growth Parameters ⓘ
Sales ⓘ	21.6	14.4	20.2	24.2	24.5	19.9	17.2	27.5	30.6	24.4	47
Sales YoY Gr.	-	-33.6%	40.5%	19.9%	1%	-18.6%	-13.5%	59.6%	11.3%	-20.3%	-
Adj EPS ⓘ	0.1	0.2	0.8	1.1	0.8	0.5	-2.3	-1.8	-0.8	-2.3	25.7
YoY Gr.	-	300%	250%	26.2%	-25.5%	-41.8%	-593.5%	NA	NA	NA	-
BVPS (₹) ⓘ	11.2	10.9	11.4	12.6	13.4	13.8	11.5	9.6	8.9	6.6	32.4
Adj Net Profit ⓘ	0	0.2	0.6	0.7	0.5	0.3	-1.6	-1.3	-0.5	-1.6	18
Cash Flow from Ops. ⓘ	0.3	-0.1	0.9	0.1	0.1	0.3	-0.2	0.7	0.1	-0	-
Debt/CF from Ops. ⓘ	0.1	-0.8	0.3	3.3	1.1	0.2	-0.2	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	1.3%	-0.1%	12.3%	-20.3%
Adj EPS ⓘ	-250.2%	-224.2%	NA	NA
BVPSⓘ	-5.7%	-13.3%	-16.9%	-25.8%
Share Price	10.8%	19.5%	48.8%	203.1%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.3	1.4	4.8	5.8	4.1	2.3	-12	-11	-4.9	-16.7	132.2
Op. Profit Mgn % ⓘ	1	0.9	2.4	3	3.4	-0.3	-10.1	-5.6	-2.7	-8.3	4
Net Profit Mgn % ⓘ	0.2	1.1	2.8	3	2.2	1.6	-9	-4.6	-1.7	-6.5	37.2
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0.1
Working Cap Days ⓘ	63	88	113	191	293	262	177	154	198	204	112
Cash Conv. Cycle ⓘ	-44	-53	-39	-47	-14	2	6	-15	-34	-51	48

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	21.61	14.36	20.18	24.20	24.45	19.90	17.22	27.49	30.59	24.37
Operating Expenses ⓘ +	21.39	14.23	19.69	23.47	23.63	19.96	18.95	29.03	31.41	26.38
Manufacturing Costs	5.58	6.27	8.93	8.10	8.36	5.28	5.84	11.08	10.03	8.79
Material Costs	4.11	4.27	7.25	11.16	12.42	12.21	10.55	14.88	18.23	14.37
Employee Cost	1.45	1.42	1.66	1.55	1.40	1.27	1.17	1.41	1.53	1.68
Other Costs ⓘ	10.26	2.27	1.84	2.65	1.46	1.20	1.40	1.66	1.63	1.54
Operating Profit ⓘ	0.22	0.13	0.49	0.73	0.82	-0.06	-1.74	-1.54	-0.82	-2.01
Operating Profit Margin (%)	1.0%	0.9%	2.4%	3.0%	3.3%	-0.3%	-10.1%	-5.6%	-2.7%	-8.3%
Other Income ⓘ +	0.53	0.58	0.69	0.60	0.58	0.89	0.47	0.52	0.66	0.75
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.01	0.01	0.04	0.04	0.04	0.01	0	0.04	0.04	0.02
Depreciation ⓘ	0.50	0.44	0.47	0.46	0.40	0.34	0.29	0.36	0.34	0.32
Profit Before Tax ⓘ	0.24	0.27	0.68	0.83	0.96	0.48	-1.56	-1.43	-0.55	-1.60
Tax ⓘ	0.20	0.10	0.11	0.05	0.42	0.17	-0.02	-0.17	-0.03	-0.01
Profit After Tax	0.04	0.16	0.57	0.78	0.54	0.31	-1.55	-1.26	-0.52	-1.59
PAT Margin (%)	0.2%	1.1%	2.8%	3.2%	2.2%	1.6%	-9.0%	-4.6%	-1.7%	-6.5%
Adjusted EPS (₹)	0.1	0.2	0.8	1.1	0.8	0.5	-2.3	-1.8	-0.8	-2.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Phaarmasia - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	11.87	11.66	12.02	12.82	13.41	13.65	12.06	10.81	10.30	8.74
Share Capital ⓘ	6.83	6.83	6.83	6.83	6.83	6.83	6.83	6.83	6.83	6.83
Reserves ⓘ	5.04	4.83	5.20	5.99	6.58	6.83	5.23	3.98	3.47	1.91
Debt +	0	0.05	0.12	0.16	0.08	0.05	0.03	0.01	0	0
Long Term Debt	0	0.05	0.12	0	0.03	0.02	0.01	0.01	0	0
Short Term Debt	0	0	0	0.16	0.05	0.03	0.02	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	3.49	5.40	7.41	17.89	18.26	6.65	8.13	16.54	20.08	11.96
Others Liabilities ⓘ	3.28	2.44	2.37	2.38	1.85	1.56	1.02	1.04	1.06	0.89
Total Liabilities ⓘ	18.63	19.54	21.92	33.26	33.60	21.91	21.24	28.40	31.43	21.59
Fixed Assets
Net Fixed Assets ⓘ +	14.11	13.74	14.18	13.80	13.40	13.06	12.76	12.79	12.48	12.32
Gross Block	34.50	14.18	15.08	15.12	15.12	15.12	15.12	15.40	15.53	15.70
Accumulated Depreciation	20.38	0.44	0.91	1.33	1.72	2.07	2.36	2.61	3.05	3.37
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.19	1.03	1.29	5.97	6.08	2.63	4.24	6.36	8.50	3.06
Trade Receivables	2.91	3.56	3.79	11.76	12.32	4.27	3.19	7.51	8.05	3.11
Cash Equivalents	0.44	0.15	0.19	0.19	0.15	0.38	0.22	0.69	0.63	0.36
Others Assets ⓘ	0.98	1.05	2.47	1.54	1.64	1.57	0.82	1.06	1.78	2.74
Total Assets ⓘ	18.63	19.54	21.92	33.26	33.60	21.91	21.24	28.40	31.43	21.59

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.28	-0.08	0.88	0.06	0.08	0.25	-0.18	0.65	0.11	-0
PBT ⓘ	0.24	0.27	0.68	0.83	0.96	0.48	-1.56	-1.43	-0.55	-1.60
Adjustment ⓘ	0.51	0.43	0.26	0.48	0.47	0.25	0.24	0.38	0.35	0.28
Changes in Working Capital ⓘ	-0.25	-0.68	0.07	-1.09	-1.09	-0.24	1.32	1.71	0.3	1.32
Tax Paid ⓘ	-0.22	-0.11	-0.13	-0.17	-0.26	-0.24	-0.17	0	0	0
Cash Flow From Investing Activity ⓘ +	-0.28	-0.18	-0.92	-0.10	-0	0	0.01	-0.01	-0	-0.12
Capex	-0.28	-0.07	-0.90	-0.08	0	0	0	-0.03	-0.03	-0.17
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	-0.11	-0.02	-0.02	-0	0	0.01	0.01	0.03	0.05
Cash Flow From Financing Activity ⓘ +	0.16	-0.02	0.08	0.04	-0.11	-0.02	0	-0.16	-0.16	-0.15
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.05	-0.02	0.08	0.04	-0.11	-0.02	0	-0.02	-0.01	0
Interest Paid ⓘ	-0.01	0	0	0	0	0	0	-0.02	-0.04	-0.02
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.13	0	0	0	0	0	0	-0.12	-0.11	-0.13
Net Cash Flow ⓘ	0.17	-0.29	0.04	-0	-0.03	0.23	-0.17	0.48	-0.06	-0.27

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.55	2.16	7.54	9.51	6.08	3.36	-17.96	-17.5	-8.21	-30.12
ROCE (%)	3.35	3.63	9.32	10.35	11.07	5.24	-18	-19.24	-7.95	-30.07
Asset Turnover Ratio	1.14	1.05	1.03	0.93	0.73	0.72	0.8	1.11	1.02	0.92
PAT to CFO Conversion(x)	7	-0.5	1.54	0.08	0.15	0.81	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	38.10	58.90	62.70	110.70	179.70	152.10	79.10	71.10	92.80	83.60
Inventory Days	12.50	11.10	19.80	51.60	89.90	80	72.90	70.40	88.60	86.60
Payable Days	286.60	379.40	322.20	413.80	531.30	372.40	255.90	302.60	366.70	406.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Phaarmasia Ltd FAQs

The current trading price of Phaarmasia on 04-Jun-2026 16:59 is ₹83.47.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Phaarmasia stood at ₹56.98 Cr

The latest P/E ratio of Phaarmasia as of 03-Jun-2026 is 3.24.

The latest P/B ratio of Phaarmasia as of 03-Jun-2026 is 2.58.

The 52-week high of Phaarmasia is ₹131.8 and the 52-week low is ₹26.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Phaarmasia is ₹47.21 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Phaarmasia Ltd is a below average quality company.

The key valuation ratios of Phaarmasia Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Phaarmasia Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Phaarmasia Ltd

The company was incorporated on February 6,1981 as Phaarmasia Private Limited, and the company was converted into a public limited company, Phaarmasia Limited on February 15, 1992, it is into manufacturing of pharmaceutical formulations. Company's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft.

The company was established for carrying on the business as manufacturers, buyers, sellers, importers, exporters, distributors, agents and or otherwise deal as wholesalers, or retailers in drugs, medicines, pharmaceuticals, chemicals and other intermediates, dyes pigments, paints, rubber chemicals, phyto chemicals, hormones, agro-chemicals, veterinary and poultry products, food and nutritional products, house-hold remedies, biological and herbal products.

Phaarmasiaâ€™s registered office is located at 16,Phase III, I.D.A Jeedimetla, Hyderabad, Andhra Pradesh 500 055, India.

The company had restructured its Paid up Share Capital account of 91,34,800 Equity Shares of Rs 10 each fully paid up as on 31st, March,2005 by reducing / debiting the amount of Rs 730.78 lakhs for setting off the Accumulated Losses of the Company and has further allotted 50,00,000 Equity Shares of Rs 10each to promoters and Associates for Rs 250 lakhs and balance to Unsecured Creditors as approved in the above Scheme of Arrangement.

Product range of the company includes:

Phaarmasiaâ€™s product range includes amexine, angicare, flamfort, nasorel, flemkof, ginadox, medix and ziron. Its amexine is an antibiotic, which is used for upper respiratory tract infections, mucolytic and expectorant.

Company also provides nasorel PR, which is a therapeutic category that comes under antihistamine and sympathomimetic.

Phaarmasia Ltd (523620)

Phaarmasia Ltd (523620)

Phaarmasia stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Phaarmasia - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Phaarmasia Ltd FAQs

About Phaarmasia Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Phaarmasia Ltd (523620)

Phaarmasia Ltd (523620)

Phaarmasia stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Phaarmasia - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Phaarmasia Ltd FAQs

What is the share price of Phaarmasia?

What is the market cap of Phaarmasia?

What is the P/E ratio of Phaarmasia?

What is the P/B ratio of Phaarmasia?

What is the 52-week high and low of Phaarmasia?

What is the TTM revenue of Phaarmasia?

Is Phaarmasia Ltd a good quality company?

Is Phaarmasia Ltd undervalued or overvalued?

Is Phaarmasia Ltd a good buy now?

About Phaarmasia Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.